HomeOVID • NASDAQ
add
Ovid Therapeutics Inc
Previous close
$0.82
Day range
$0.75 - $0.88
Year range
$0.68 - $4.10
Market cap
56.97M USD
Avg Volume
315.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
WSJ
1 hour ago
Stock Market Today: Nasdaq, S&P 500 Fall; Nvidia, Macy's Stocks in Focus —
Live Updates
8.04%
2.58%
0.015%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 173.00K | 58.72% |
Operating expense | 13.40M | 10.39% |
Net income | -14.01M | -24.46% |
Net profit margin | -8.10K | 21.58% |
Earnings per share | -0.20 | — |
EBITDA | -13.06M | -9.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.71M | -27.98% |
Total assets | 102.65M | -17.90% |
Total liabilities | 26.36M | 11.07% |
Total equity | 76.29M | — |
Shares outstanding | 71.01M | — |
Price to book | 0.77 | — |
Return on assets | -29.96% | — |
Return on capital | -33.80% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.01M | -24.46% |
Cash from operations | -15.01M | -49.29% |
Cash from investing | 292.00K | 106.70% |
Cash from financing | 38.00K | -83.04% |
Net change in cash | -14.68M | -3.45% |
Free cash flow | -8.50M | -30.85% |
About
Founded
2014
Website
Employees
25
